View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pall Corporation
20 October 2017

Pall Corporation Introduces Stax mAx

The Stax mAx clarification platform is a single-use, robust depth filtration solution for the economic clarification of monoclonal antibody cell cultures without the need for centrifugation or process additives.

The platform is optimised to maintain performance as cell density and viability change to minimise the impact of process variability between batches and to deliver a platform that retains a small footprint across a wide range of feed streams with cell densities of up 35 x 106 cells/ml and feed turbidities of up to 3,000 NTU.

The platform applies two stages of filtration, each with two layers of pharmaceutical grade depth-filter media with sequentially finer grades to remove aggregates, whole cells and cell debris. This construction produces a consistent low turbidity effluent with a consistent high throughput even as cell density increases or cell viability decreases.

The same media configurations are available in a number of formats to scale directly from bench-top testing up to large-scale clinical production.

The combination of robust performance, scalability and simplicity make the Stax mAx clarification platform the right choice to accelerate process development and to provide high quality filtrate in a low footprint, economic system.

 

Selecting the right filter integrity test instrument is an important task. An informed, balanced choice will support seamless integration of the instrument into critical processes...
Founded by Dr David B Pall in 1946, Pall Corporation has grown from a company producing filters for the airline industry to a global innovator...
Recent advances in personalised regenerative medicine have been significant. However, further developments are needed to support market and regulatory demands, particularly the development of manufacturing...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology